Results 161 to 170 of about 42,597 (192)

Molecularly targeted therapy and immunotherapy in leukemias. [PDF]

J Hematol Oncol
Cousin E, Picard A, Oundjian M, Tardif N, Quemener A, Rio AG, Galibert MD, Gandemer V, Mazurier F.   +8 more
europepmc   +1 more source

Evaluation of iron accumulation during childhood cancer treatment. [PDF]

Front Pediatr
Çalışkan Kamış Ş, Çil M, Yağcı B, Karagün BŞ.   +3 more
europepmc   +1 more source

Ferroptosis: a new dawn in the treatment of acute lymphoblastic leukemia. [PDF]

Front Oncol
Han J, Yang Y, Wei Y, Jin J, Feng W.
europepmc   +1 more source

Multiple facial neoplasms in a pediatric patient during treatment for B-lymphoblastic leukemia/lymphoma. [PDF]

Proc (Bayl Univ Med Cent)
Strickland T, Conlon M, Fike J.
europepmc   +1 more source

Artificial inteligence and datasets for leukemia diagnosis: A scoping review of machine lerning and deep learning approaches. [PDF]

MethodsX
Tande A, Mane R.
europepmc   +1 more source

Olive Leaf Extract (OLE) Anti-Tumor Activities Against Hematologic Tumors: Potential Therapeutic Implications for Pediatric Patients with B-Acute Lymphoblastic Leukemia. [PDF]

Nutrients
Airoldi I, Canè L, Brignole C, Ciampi E, Montagna D, Morandi F.   +5 more
europepmc   +1 more source

A Rare Presentation of Sphenoid Sinus Lymphoma in an 18-Year-Old Female. [PDF]

Cureus
Binsanad N, Fakhroo L, Darwish A, Alomran B, Albalooshi M.   +4 more
europepmc   +1 more source

CD94 as a novel marker for immunophenotyping of leukemia and lymphoma in dogs. [PDF]

Front Vet Sci
Blockeel A, Demeyere K, Steenbrugge J, Paepe D, Krupa A, Martini V, Devriendt B, Meyer E.   +7 more
europepmc   +1 more source

Systemic CD3+ T-Cell Lymphoblastic Leukemia in a Bearded Dragon (<i>Pogona vitticeps)</i>: Clinical, Therapeutic, and Pathological Findings. [PDF]

Animals (Basel)
Miljković J, Jonker A, Đuričić D, Horvatek Tomić D, Belić M, Faraguna S, Pavić Vulinović M, Shek Vugrovečki A, Lukač M, Šoštarić-Zuckermann IC, Šmit I.   +10 more
europepmc   +1 more source

Can one scoring system fit all? Comparative validation of CAR-HEMATOTOX, ALL-HEMATOTOX, and eIPM for predicting immune effector cell-associated hematotoxicity following CAR-T therapy in hematologic malignancies. [PDF]

Chin J Cancer Res
Zhang A, Zheng H, Shang Q, Yin X, Yang Y, Luo Y, Su T, Dou X, Zhao T, Pei X, Liu Z, Lu J, Zhang X, Huang X, Mo X, Lv M, Zhao X.   +16 more
europepmc   +1 more source